In order to generate a consistent ROR1+ tumor model in huNSG mice, we have to improve the transduction efficiency of CD34+ cells and achieve a higher engraftment of TCL-1-transduced CD34+ cells [37]. The gene discussed is ROR1; the disease is neoplasm.